Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate
22nd Nov 2005, 20:32 GMT
Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostate related news:
- Prostate size matters say US scientists — HEALTH
- Smaller prostate size, more aggressive cancer — Health News Online - Medical and health information and tools from Armenian Medical Network
- Australian prostate cancer drug shows promise — KeralaNext: Science
- Daily pill may beat prostate cancer — HEALTH
- USPS October Financials — postalnews.com
- Volume of total exports of goods increased by 11.4% in HK — People's Daily Online
- IsoRay Medical's Cesium-131 Brachytherapy Treatment Combined with External Beam Radiation Therapy for the 1st Time at the Arnold Palmer Prostate Center at Eisenhower Med Cntr — Radiology News from StratCenter.com
- Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer — Prostate Cancer and Prostatic Diseases
- Volume 32, number 3: Behavioral Consequences of Affect: Combining Evaluative and Regulatory Mechanisms — JCR Latest Issue
- Important: Transition your MSDN Account — A blog to the tune of James